{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:56:34Z","timestamp":1794448594070,"version":"4.9.1"},"reference-count":34,"publisher":"The Journal of Rheumatology","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Few factors have consistently been linked to antibiotic-refractory Lyme arthritis (ARLA). We sought to identify clinical and treatment factors associated with pediatric ARLA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We performed a case-control study in 3 pediatric rheumatology clinics in a Lyme-endemic region (2000\u20132013). Eligible children were aged \u2264 18 years with arthritis and had positive testing for Lyme disease by Western blot. Cases were 49 children with persistently active arthritis despite \u2265 8 weeks of oral antibiotics or \u2265 2 weeks of parenteral antibiotics; controls were 188 children whose arthritis resolved within 3 months of starting antibiotics. We compared preselected demographic, clinical, and treatment factors between groups using logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Characteristics positively associated with ARLA were age \u2265 10 years, prolonged arthritis at diagnosis, knee-only arthritis, and worsening after starting antibiotics. In contrast, children with fever, severe pain, or other signs of systemic inflammation were more likely to respond quickly to treatment. Secondarily, low-dose amoxicillin and treatment nonadherence were also linked to higher risk of ARLA. Greater antibiotic use for children with ARLA was accompanied by higher rates of treatment-associated adverse events (37% vs 15%) and resultant hospitalization (6% vs 1%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Older children and those with prolonged arthritis, arthritis limited to the knees, or poor initial response to antibiotics are more likely to have antibiotic-refractory disease and treatment-associated toxicity. Children with severe symptoms of systemic inflammation have more favorable outcomes. For children with persistently active Lyme arthritis after 2 antibiotic courses, pediatricians should consider starting antiinflammatory treatment and referring to a pediatric rheumatologist.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.180775","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T17:25:50Z","timestamp":1551461150000},"page":"943-951","source":"Crossref","is-referenced-by-count":19,"title":["Pediatric Antibiotic-refractory Lyme Arthritis: A Multicenter Case-control Study"],"prefix":"10.3899","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1831-1339","authenticated-orcid":false,"given":"Daniel B.","family":"Horton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysha J.","family":"Taxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3660-7627","authenticated-orcid":false,"given":"Amy L.","family":"Davidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandt","family":"Groh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Sherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos D.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"key":"2019080109250535000_46.8.943.1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6609a1"},{"key":"2019080109250535000_46.8.943.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610243351703"},{"key":"2019080109250535000_46.8.943.3","doi-asserted-by":"publisher","DOI":"10.1086\/508667"},{"key":"2019080109250535000_46.8.943.4","unstructured":"American Academy of Pediatrics . Lyme disease. In: Kimberlin DW Brady MT Jackson MA Long SS , editors. Red book: 2015 report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village: American Academy of Pediatrics; 2015:516\u201325."},{"key":"2019080109250535000_46.8.943.5","doi-asserted-by":"publisher","DOI":"10.1002\/art.22131"},{"key":"2019080109250535000_46.8.943.6","first-page":"2025","article-title":"Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy","volume":"27","author":"Bentas","year":"2000","journal-title":"J Rheumatol"},{"key":"2019080109250535000_46.8.943.7","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090711"},{"key":"2019080109250535000_46.8.943.8","doi-asserted-by":"crossref","first-page":"A38","DOI":"10.1186\/1546-0096-10-S1-A38","article-title":"Lyme arthritis outcomes in children: a single center cohort study","volume":"Suppl 1","author":"Groh","year":"2012","journal-title":"Pediatr Rheumatol"},{"key":"2019080109250535000_46.8.943.9","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1100-8"},{"key":"2019080109250535000_46.8.943.10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00296-013-2923-9","article-title":"Intraarticular corticosteroids in refractory childhood Lyme arthritis","volume":"34","author":"Nimmrich","year":"2014","journal-title":"Rheumatol Int"},{"key":"2019080109250535000_46.8.943.11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780380310","article-title":"Lyme arthritis in European children and adolescents. The Pediatric Rheumatology Collaborative Group","volume":"38","author":"Huppertz","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2019080109250535000_46.8.943.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107123450202"},{"key":"2019080109250535000_46.8.943.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505425"},{"key":"2019080109250535000_46.8.943.14","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0340-2"},{"key":"2019080109250535000_46.8.943.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2393"},{"key":"2019080109250535000_46.8.943.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2019080109250535000_46.8.943.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007263230402"},{"key":"2019080109250535000_46.8.943.18","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1128\/IAI.61.7.2774-2779.1993","article-title":"Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi","volume":"61","author":"Kalish","year":"1993","journal-title":"Infect Immun"},{"key":"2019080109250535000_46.8.943.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.34383"},{"key":"2019080109250535000_46.8.943.20","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/art.38618","article-title":"Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory Lyme arthritis","volume":"66","author":"Londo\u00f1o","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2019080109250535000_46.8.943.21","doi-asserted-by":"publisher","DOI":"10.1002\/art.27468"},{"key":"2019080109250535000_46.8.943.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.37910"},{"key":"2019080109250535000_46.8.943.23","first-page":"930","article-title":"T-helper 17 cell cytokine responses in Lyme disease correlate with Borrelia burgdorferi antibodies during early infection and with autoantibodies late in the illness in patients with antibiotic-refractory Lyme arthritis","volume":"64","author":"Strle","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2019080109250535000_46.8.943.24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/art.40039","article-title":"MicroRNA expression shows inflammatory dysregulation and tumor-like proliferative responses in joints of patients with postinfectious Lyme arthritis","volume":"69","author":"Lochhead","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2019080109250535000_46.8.943.25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI58813"},{"key":"2019080109250535000_46.8.943.26","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-1964-x"},{"key":"2019080109250535000_46.8.943.27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.40350","article-title":"Review: genetics and the classification of arthritis in adults and children","volume":"70","author":"Nigrovic","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2019080109250535000_46.8.943.28","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit269"},{"key":"2019080109250535000_46.8.943.29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit735"},{"key":"2019080109250535000_46.8.943.30","doi-asserted-by":"crossref","unstructured":"Horton DB Taxter AJ Davidow AL Groh B Sherry DD Rose CD . Intraarticular glucocorticoid injection as second-line treatment for Lyme arthritis in children. J Rheumatol 2019 (accepted for publication).","DOI":"10.3899\/jrheum.180829"},{"key":"2019080109250535000_46.8.943.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401273300401"},{"key":"2019080109250535000_46.8.943.32","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199912)42:12<2705::AID-ANR29>3.0.CO;2-H"},{"key":"2019080109250535000_46.8.943.33","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-0036"},{"key":"2019080109250535000_46.8.943.34","doi-asserted-by":"crossref","first-page":"e160217","DOI":"10.1001\/jamapediatrics.2016.0217","article-title":"Epidemiology of Clostridium difficile infection-associated reactive arthritis in children: an underdiagnosed, potentially morbid condition","volume":"170","author":"Horton","year":"2016","journal-title":"JAMA Pediatr"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.180775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T01:31:34Z","timestamp":1606613494000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.180775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,1]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.3899\/jrheum.180775"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.180775","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}